pf 5901 has been researched along with Shock, Septic in 1 studies
alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol: structure given in first source; platelet activating factor antagonist
Shock, Septic: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hogaboam, CM | 1 |
| Donigi-Gale, D | 1 |
| Shoupe, TS | 1 |
| Wallace, JL | 1 |
1 other study available for pf 5901 and Shock, Septic
| Article | Year |
|---|---|
PF-5901 inhibits gastrointestinal platelet-activating factor synthesis in vivo.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Intestinal Mucosa; Jejunum; | 1992 |